138 related articles for article (PubMed ID: 20348226)
21. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Hedelin P; Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
[TBL] [Abstract][Full Text] [Related]
22. Role of endothelin in alpha-adrenoceptor coronary vasoconstriction.
Gorman MW; Farias M; Richmond KN; Tune JD; Feigl EO
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1937-42. PubMed ID: 15591092
[TBL] [Abstract][Full Text] [Related]
23. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P-450 2C9 exerts a vasoconstrictor influence on coronary resistance vessels in swine at rest and during exercise.
Zhou Z; Hemradj V; de Beer VJ; Gao F; Hoekstra M; Merkus D; Duncker DJ
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1747-55. PubMed ID: 22307673
[TBL] [Abstract][Full Text] [Related]
25. AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction.
Schuijt MP; Basdew M; van Veghel R; de Vries R; Saxena PR; Schoemaker RG; Danser AH
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2590-6. PubMed ID: 11709427
[TBL] [Abstract][Full Text] [Related]
26. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation.
Moltzer E; Verkuil AV; van Veghel R; Danser AH; van Esch JH
Hypertension; 2010 Feb; 55(2):516-22. PubMed ID: 20026759
[TBL] [Abstract][Full Text] [Related]
27. 20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.
Tsai IJ; Croft KD; Puddey IB; Beilin LJ; Barden A
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1194-200. PubMed ID: 21239640
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
29. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine.
Stebbins CL; Symons JD
J Appl Physiol (1985); 1995 Jan; 78(1):185-90. PubMed ID: 7713810
[TBL] [Abstract][Full Text] [Related]
30. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Zhang C; Hein TW; Wang W; Kuo L
Circ Res; 2003 Feb; 92(3):322-9. PubMed ID: 12595345
[TBL] [Abstract][Full Text] [Related]
31. Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds.
Gomez-Alamillo C; Juncos LA; Cases A; Haas JA; Romero JC
Hypertension; 2003 Oct; 42(4):831-6. PubMed ID: 12925563
[TBL] [Abstract][Full Text] [Related]
32. Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
Wang M; Shibamoto T; Kuda Y; Tanida M; Kurata Y
Exp Lung Res; 2015; 41(6):324-34. PubMed ID: 26151368
[TBL] [Abstract][Full Text] [Related]
33. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
MaassenVanDenBrink A; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Cardiovasc Res; 1999 Nov; 44(2):407-15. PubMed ID: 10690317
[TBL] [Abstract][Full Text] [Related]
34. Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.
Taverne YJ; de Wijs-Meijler D; Te Lintel Hekkert M; Moon-Massat PF; Dubé GP; Duncker DJ; Merkus D
J Appl Physiol (1985); 2017 May; 122(5):1227-1237. PubMed ID: 28183818
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.
Lin YJ; Kwok CF; Juan CC; Hsu YP; Shih KC; Chen CC; Ho LT
Biochem Biophys Res Commun; 2014 Aug; 451(2):263-9. PubMed ID: 25088996
[TBL] [Abstract][Full Text] [Related]
36. Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
Schuijt MP; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Br J Pharmacol; 2002 Jan; 135(1):275-83. PubMed ID: 11786504
[TBL] [Abstract][Full Text] [Related]
37. Role for endothelin-1 in angiotensin II-mediated hypertension.
Rajagopalan S; Laursen JB; Borthayre A; Kurz S; Keiser J; Haleen S; Giaid A; Harrison DG
Hypertension; 1997 Jul; 30(1 Pt 1):29-34. PubMed ID: 9231817
[TBL] [Abstract][Full Text] [Related]
38. Impaired pulmonary vasomotor control in exercising swine with multiple comorbidities.
van de Wouw J; Steenhorst JJ; Sorop O; van Drie RWA; Wielopolski PA; Kleinjan A; Hirsch A; Duncker DJ; Merkus D
Basic Res Cardiol; 2021 Sep; 116(1):51. PubMed ID: 34510273
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
